TR201306238A2 - A composition for the treatment of attention and concentration deficit disorders - Google Patents

A composition for the treatment of attention and concentration deficit disorders

Info

Publication number
TR201306238A2
TR201306238A2 TR2013/06238A TR201306238A TR201306238A2 TR 201306238 A2 TR201306238 A2 TR 201306238A2 TR 2013/06238 A TR2013/06238 A TR 2013/06238A TR 201306238 A TR201306238 A TR 201306238A TR 201306238 A2 TR201306238 A2 TR 201306238A2
Authority
TR
Turkey
Prior art keywords
attention
treatment
composition
deficit disorders
concentration deficit
Prior art date
Application number
TR2013/06238A
Other languages
Turkish (tr)
Inventor
Can Alkoçlar Erdal
Yeşi̇l Metehan
Original Assignee
Metehan Yesil
Erdal Can Alkoclar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metehan Yesil, Erdal Can Alkoclar filed Critical Metehan Yesil
Priority to TR2013/06238A priority Critical patent/TR201306238A2/en
Publication of TR201306238A2 publication Critical patent/TR201306238A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Buluş, dikkat ve konsantrasyon bozukluklarının tedavisine yönelik oluşturulmuş bir kompozisyon ile ilgilidir.The invention relates to a composition formed for the treatment of attention and concentration disorders.

TR2013/06238A 2013-05-24 2013-05-24 A composition for the treatment of attention and concentration deficit disorders TR201306238A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2013/06238A TR201306238A2 (en) 2013-05-24 2013-05-24 A composition for the treatment of attention and concentration deficit disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2013/06238A TR201306238A2 (en) 2013-05-24 2013-05-24 A composition for the treatment of attention and concentration deficit disorders

Publications (1)

Publication Number Publication Date
TR201306238A2 true TR201306238A2 (en) 2014-01-21

Family

ID=67901110

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2013/06238A TR201306238A2 (en) 2013-05-24 2013-05-24 A composition for the treatment of attention and concentration deficit disorders

Country Status (1)

Country Link
TR (1) TR201306238A2 (en)

Similar Documents

Publication Publication Date Title
CY1118168T1 (en) DOUBLE SPECIAL ANTIBODIES AGAINST CD3EXYLON AND BCMA
PH12016501763A1 (en) Multispecific antibodies
TR201811764T4 (en) Aminoheteroaryl benzamides as kinase inhibitors.
TR201905829T4 (en) A refrigerator.
CL2015002562A1 (en) Anti-b7-h4 antibodies and immunoconjugates
EA201691214A1 (en) ANTIBODIES TO CD33 AND IMMUNOCONJUGATES
EA201691765A1 (en) ANTIBODY MOLECULES AGAINST LAG-3 AND THEIR APPLICATIONS
EA201491811A1 (en) ANTI-LgR5 ANTIBODIES AND IMMUNOCONJUGATES
MX2016003129A (en) Combination therapy of antibodies against human csf-1r and antibodies against human pd-l1.
EA201690280A1 (en) COMPOSITIONS AND METHODS RELATED TO Dedicated ENDOPHITES
UY34721A (en) ANTI-HLA-B * 27 ANTIBODIES AND USES OF THESE.
EA201491947A1 (en) ANTIBODIES AND IMMUNOCONJUGATES TO LY6E AND METHODS OF APPLICATION
EA201590997A1 (en) CONNECTIONS AND METHODS OF THEIR APPLICATION
UY34817A (en) TIENOPIRIMIDINS
EA201792612A1 (en) 6-AMINOHINOLIN-3-CARBONITRILES AS COT MODULATORS
UY4223Q (en) BANK
EA201590503A1 (en) ALPHA-1-Microglobulin for use in the treatment of diseases associated with mitochondria
TR201904120T4 (en) Connector part.
TR201905787T4 (en) Lyophilized TAT-NR2B9C formulation.
AR097668A1 (en) COLOR-POLYMER
CY1119470T1 (en) LACTIC PHOSPHATIDYLSERIN-BASED COMPOSITIONS
TR201904143T4 (en) Silylated polyurethanes.
BR112015022234A2 (en) solid lipid nanoparticles (ii)
EA201691036A1 (en) NEW CONNECTION FOR THE TREATMENT OF HEAVY HYPOGLYCEMIA
EA201690914A1 (en) NEW CONNECTION FOR THE TREATMENT OF HEAVY HYPOGLYCEMIA